Recovery Rate From Category II to Category I EFM Tracings in Pregnant Women Receiving Bolus vs Co… (NCT07260240) | Clinical Trial Compass
CompletedNot Applicable
Recovery Rate From Category II to Category I EFM Tracings in Pregnant Women Receiving Bolus vs Continuous Intravenous Fluid Administration
Thailand60 participantsStarted 2025-12-10
Plain-language summary
The goal of this clinical trial is to learn which method of intravenous fluid works better for treating abnormal fetal heart rate patterns during labour in low-risk pregnant women at term. The main question it aims to answer is:
Does a rapid fluid bolus (500 mL given quickly) convert abnormal fetal heart rate tracings to normal within 30 minutes better than slow continuous infusion? Researchers will compare a 500 mL normal saline bolus followed by continuous infusion to continuous infusion alone to see which method improves fetal heart rate patterns faster.
Participants will:
* Be placed in the left lateral position and receive supplemental oxygen by face mask
* Have oxytocin stopped if it is being given
* Receive normal saline through an IV line - either as a rapid bolus or a slow continuous drip, depending on which group they are assigned to
* Have fetal heart rate monitored continuously and assessed at 30, 60, and 120 minutes
* Have blood pressure, heart rate, and oxygen levels checked every 15 minutes
* Have two ultrasound measurements taken - one of a vein in the abdomen and one of blood flow in the umbilical cord - at the start and at 30 minutes
Who can participate
Age range
20 Years – 35 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Recovery rate from Category II to Category I EFM tracing at 30 minutes
Timeframe: 30 minutes
Trial details
NCT IDNCT07260240
SponsorQueen Savang Vadhana Memorial Hospital, Thailand